Dow Inc. — Cyborg Score 4/10

Mixed
Chemicals

Strategic Profile

CEO Fitterling emphasized a cost-advantaged growth strategy amid Middle East geopolitical risks, oil price volatility, and construction market headwinds. The Packaging and Specialty Plastics segment led 3% sequential volume growth, and cost-saving initiatives delivered $193M in savings with $873M operating EBITDA in Q1 2026. The company maintains reasonable liquidity with $4B cash, $14B total liquidity, and a 1.97 current ratio, though profitability remains under pressure.

Cyborg Score Rationale

Dow faces significant near-term headwinds with Q1 2026 losses and declining revenues, but shows operational discipline through cost-reduction successes and segment recovery momentum. The company's 2026 EPS turnaround guidance and liquidity position provide some stabilization, though pricing pressure and geopolitical risks pose downside risks.

Top Insights

  • Q1 2026 showed mixed signals: revenue beat estimates (+1.55%) but EPS missed significantly (-187%), with net losses widening 72% YoY despite cost-saving wins of $193M
  • Dow's 2026 EPS guidance of $0.69 implies substantial improvement from -$3.70 LTM, contingent on the Transform to Outperform program execution
  • Chemical industry fundamentals remain soft with pricing pressure offsetting volume gains; Dow's segment growth concentrated in higher-margin Packaging & Specialty Plastics
  • Strong balance sheet liquidity ($14B) and 3.61% dividend yield provide downside support, but 6.23% gross profit margin weakness signals competitive intensity

Named Competitors

  • Linde — Industrial gases and chemicals
  • Huntsman — Specialty chemicals and plastics
  • Westlake — Plastics and petrochemicals

Recent Developments

  • (April 2026) Q1 2026 earnings: revenue $9.8B (slight beat), EPS -$0.74 GAAP but -$0.14 operating EPS beat analyst estimates
  • (April 2026) Cost-saving initiatives delivered $193M in savings; Packaging and Specialty Plastics segment posted 3% sequential volume growth
  • (Q1 2026) Company suspended Sadara equity loss recognition and resolved Nova Chemicals litigation with payment received

Open the full interactive Dow Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →